U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004816) titled 'The Mutation Profile and Prognosis in AML With IDH1/2 Mutation' on May 26.
Brief Summary: We have a prospective clinical cohort including 500 adult AML patients. And we have stored leukemia sample from these patients. In this program we will do mutation profile in these patients. Also, we will elucidate the incidence of IDH1/2 mutations in adult AML in China and elucidate the prognostic effect of IDH1/2 mutation in AML.
Study Start Date: Dec. 21, 2017
Study Type: OBSERVATIONAL
Condition:
AML
Intervention:
OTHER: Uncover mutation profiles
Uncover mutation profiles
Recruitment Status: COMPLETED
Sponsor: Institute of Hematology...